Jun Lü

4.0k total citations
181 papers, 2.7k citations indexed

About

Jun Lü is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Lü has authored 181 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 74 papers in Molecular Biology and 72 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Lü's work include Lung Cancer Treatments and Mutations (36 papers), Lung Cancer Research Studies (29 papers) and Pancreatic and Hepatic Oncology Research (24 papers). Jun Lü is often cited by papers focused on Lung Cancer Treatments and Mutations (36 papers), Lung Cancer Research Studies (29 papers) and Pancreatic and Hepatic Oncology Research (24 papers). Jun Lü collaborates with scholars based in China, United States and Australia. Jun Lü's co-authors include Baohui Han, Junchao Guo, Li Zhou, Yizhi Wang, Xiaodong Zhao, Minghao Fang, Ruichao Li, Fankai Meng, Shun Ke and Yanwei Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.

In The Last Decade

Jun Lü

167 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Lü China 28 1.4k 946 863 608 258 181 2.7k
Caigang Liu China 26 1.4k 1.0× 877 0.9× 850 1.0× 531 0.9× 324 1.3× 132 2.7k
Lin Xia China 28 1.5k 1.1× 1.1k 1.1× 615 0.7× 398 0.7× 320 1.2× 84 2.8k
Germana Castelli Italy 29 1.6k 1.2× 950 1.0× 798 0.9× 478 0.8× 228 0.9× 97 3.1k
Xinchen Sun China 28 1.2k 0.8× 577 0.6× 706 0.8× 509 0.8× 417 1.6× 133 2.3k
Wei He China 27 1.3k 1.0× 797 0.8× 558 0.6× 526 0.9× 338 1.3× 134 2.9k
Carmine Carbone Italy 29 1.2k 0.8× 537 0.6× 911 1.1× 385 0.6× 246 1.0× 84 2.3k
Naoya Sakamoto Japan 32 1.8k 1.3× 1.0k 1.1× 1.1k 1.3× 624 1.0× 433 1.7× 172 3.2k
Shancheng Ren China 30 2.1k 1.5× 1.4k 1.5× 895 1.0× 992 1.6× 236 0.9× 78 3.5k
Jianwei Xu China 31 1.2k 0.8× 900 1.0× 951 1.1× 304 0.5× 401 1.6× 93 2.5k
Humam Kadara United States 34 1.8k 1.3× 900 1.0× 1.1k 1.3× 914 1.5× 142 0.6× 95 3.2k

Countries citing papers authored by Jun Lü

Since Specialization
Citations

This map shows the geographic impact of Jun Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Lü more than expected).

Fields of papers citing papers by Jun Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Lü. The network helps show where Jun Lü may publish in the future.

Co-authorship network of co-authors of Jun Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Lü. A scholar is included among the top collaborators of Jun Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Lü. Jun Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Faji, Qirong Jiang, Zheyu Niu, et al.. (2025). Density of tertiary lymphoid structures predict clinical outcome in hepatoblastoma. Pediatric Research. 99(3). 1023–1031. 1 indexed citations
2.
Zhou, Chao, Yuqing Liu, Hongyu Liu, et al.. (2025). WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer. Cell Death and Disease. 16(1). 661–661.
3.
Liu, Hongyu, Chao Zhou, Jun Lü, et al.. (2025). Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer. Cell Death and Disease. 16(1). 356–356.
4.
Zhong, Hua, et al.. (2025). Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China. Journal of Comparative Effectiveness Research. 14(2). e240043–e240043. 4 indexed citations
5.
Zhang, Yanwei, Beibei Sun, Jun Lü, et al.. (2024). Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinoma. npj Precision Oncology. 8(1). 50–50. 8 indexed citations
6.
Hu, Yixin, Lijun Gao, Zhiheng Li, et al.. (2024). Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia. Leukemia. 39(1). 98–111. 4 indexed citations
7.
Zheng, Liang, Fang Hu, Lin Huang, et al.. (2024). Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer. 12(4). e008190–e008190. 6 indexed citations
8.
Xu, Jianlin, Shuyuan Wang, Runbo Zhong, et al.. (2023). On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer. Frontiers in Immunology. 14. 1173025–1173025. 3 indexed citations
9.
Lü, Jun, Yuqing Lou, Yanwei Zhang, et al.. (2023). Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery. International Journal of Nanomedicine. Volume 18. 263–276. 10 indexed citations
10.
Mei, Heng, Hu Zhou, Ming Hou, et al.. (2023). Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China. Research and Practice in Thrombosis and Haemostasis. 7(6). 102158–102158. 9 indexed citations
11.
Lü, Jun, Huiping Qiang, Mingfang Lu, et al.. (2023). Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming. Advanced Therapeutics. 6(11). 5 indexed citations
12.
Morris, Montana T., Abhishek Jain, Boshi Sun, et al.. (2023). Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis. Cancer Letters. 574. 216384–216384. 13 indexed citations
13.
14.
Lü, Jun, Bo Han, Bo Zhang, et al.. (2023). PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs. Journal of Controlled Release. 362. 197–209. 4 indexed citations
15.
16.
Yu, Xiongfei, Yiran Chen, Jun Lü, et al.. (2022). Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study. Frontiers in Oncology. 12. 985154–985154. 6 indexed citations
17.
Xu, Wei, Jun Lü, Qiang Zhao, et al.. (2019). Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer. Disease Markers. 2019. 1–7. 41 indexed citations
18.
Sun, Chong, Shuang Cai, Wenhua Zhu, et al.. (2018). A clinical and natural history research on mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Chin J Neurol. 51(2). 118–123. 1 indexed citations
19.
Zhang, Qingquan, Ru Chih C. Huang, Xiaoxia Guo, et al.. (2017). The temporal requirements for Isl1 in sympathetic neuron proliferation, differentiation and diversification. Mechanisms of Development. 145. S125–S125. 4 indexed citations
20.
Ren, Wei, Feng Jiang, Jun Lü, et al.. (2014). CCAAT/Enhancer-Binding ProteinαIs a Crucial Regulator of Human Fat Mass and Obesity Associated Gene Transcription and Expression. BioMed Research International. 2014. 1–7. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caigang Liu Breakdown of academic impact, for papers by Lin Xia Breakdown of academic impact, for papers by Germana Castelli Breakdown of academic impact, for papers by Xinchen Sun Breakdown of academic impact, for papers by Wei He Breakdown of academic impact, for papers by Carmine Carbone Breakdown of academic impact, for papers by Naoya Sakamoto Breakdown of academic impact, for papers by Shancheng Ren Breakdown of academic impact, for papers by Jianwei Xu Breakdown of academic impact, for papers by Humam Kadara
Rankless by CCL
2026